Center on Reproductive Health, Law, and Policy, UCLA (University of California, Los Angeles) School of Law.
School of Public Health, University of California, Berkeley.
JAMA Netw Open. 2024 Apr 1;7(4):e246018. doi: 10.1001/jamanetworkopen.2024.6018.
Nearly half of US states have restricted abortion access. Policy makers are exploring pathways to increase access to abortion and reproductive health care more broadly. Since 2016, California pharmacists could prescribe hormonal birth control, providing an opportunity to learn about the implementation of pharmacist-provided reproductive health care.
To explore the feasibility of broadening pharmacist scope of practice to include prescribing medication abortion.
DESIGN, SETTING, AND PARTICIPANTS: A cross-sectional online survey was conducted from October 11 to December 20, 2022, among a convenience sample of California licensed community pharmacists to examine their attitudes toward, knowledge of, and confidence in prescribing hormonal birth control and reports of pharmacy-level practices.
Descriptive analyses and log-binomial regression models were used to compare medication abortion and contraceptive provision attitudes by pharmacist and pharmacy characteristics.
Among the 316 pharmacists included in the analysis who worked at community pharmacies across California (mean [SD] age, 40.9 [12.0] years; 169 of 285 [59.3%] cisgender women; and 159 of 272 [58.5%] non-Hispanic Asian individuals), most (193 of 280 [68.9%]) indicated willingness to prescribe medication abortion to pharmacy clients if allowed by law. However, less than half were confident in their knowledge of medication abortion (139 of 288 [48.3%]) or their ability to prescribe it (115 of 285 [40.4%]). Pharmacists who indicated that providing access to hormonal birth control as a prescribing provider was important (263 of 289 [91.0%]) and were confident in their ability to prescribe it (207 of 290 [71.4%]) were 3.96 (95% CI, 1.80-8.73) times and 2.44 (95% CI, 1.56-3.82) times more likely to be willing to prescribe medication abortion and to express confidence in doing so, respectively. Although most pharmacists held favorable attitudes toward hormonal birth control, less than half (144 of 308 [46.8%]) worked in a pharmacy that provided prescriptions for hormonal birth control, and 149 who did not reported barriers such as lack of knowledge or training (65 [43.6%]), insufficient staff or time to add new services (58 [38.9%]), and lack of coverage for services (50 [33.6%]).
The findings of this cross-sectional survey study of California pharmacists suggest that most pharmacists were willing to prescribe medication abortion. However, future efforts to expand pharmacists' scope of practice should include training to increase knowledge and confidence in prescribing medication abortion. Pharmacy-level barriers to hormonal birth control prescription, such as insurance coverage for pharmacist effort, should also be addressed, as they may serve as barriers to medication abortion access.
近一半的美国州已经限制了堕胎的可及性。政策制定者正在探索扩大获取堕胎和更广泛的生殖保健的途径。自 2016 年以来,加州药剂师可以开处方荷尔蒙避孕药,这为了解药剂师提供生殖保健的实施情况提供了机会。
探索扩大药剂师的实践范围,包括开处方药物流产的可行性。
设计、设置和参与者:2022 年 10 月 11 日至 12 月 20 日,对加利福尼亚州的有执照社区药剂师进行了横断面在线调查,以了解他们对开处方荷尔蒙避孕药的态度、知识和信心,并报告了药房层面的实践情况。
描述性分析和对数二项式回归模型用于比较药剂师和药房特征与药物流产和避孕提供态度相关的结果。
在参与分析的 316 名在加利福尼亚州各地社区药房工作的药剂师中(平均[标准差]年龄为 40.9[12.0]岁;285 名药剂师中有 169 名[59.3%]为跨性别女性;272 名药剂师中有 159 名[58.5%]为非西班牙裔亚裔个体),大多数(280 名药剂师中有 193 名[68.9%])表示如果法律允许,愿意为药房客户开处方药物流产。然而,不到一半的药剂师对药物流产的知识(288 名药剂师中有 139 名[48.3%])或开处方的能力(285 名药剂师中有 115 名[40.4%])有信心。表示提供荷尔蒙避孕药作为处方提供者很重要(289 名药剂师中有 263 名[91.0%])且对自己的开处方能力有信心(290 名药剂师中有 207 名[71.4%])的药剂师分别有 3.96(95%CI,1.80-8.73)倍和 2.44(95%CI,1.56-3.82)倍更愿意开处方药物流产并对这样做表示有信心。尽管大多数药剂师对荷尔蒙避孕药持有利态度,但只有不到一半(308 名药剂师中有 144 名[46.8%])在提供荷尔蒙避孕药处方的药房工作,而 149 名没有提供处方的药剂师报告了诸如缺乏知识或培训(65[43.6%])、缺乏足够的员工或时间来增加新服务(58[38.9%])以及缺乏服务覆盖范围(50[33.6%])等障碍。
这项对加利福尼亚州药剂师的横断面调查研究的结果表明,大多数药剂师愿意开处方药物流产。然而,未来扩大药剂师实践范围的努力应包括培训,以增加开处方药物流产的知识和信心。还应解决荷尔蒙避孕药处方的药房层面障碍,例如为药剂师的努力提供保险,因为这些障碍可能成为药物流产获得的障碍。